These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 29963201)

  • 21. WT1 peptide vaccine as a paradigm for "cancer antigen-derived peptide"-based immunotherapy for malignancies: successful induction of anti-cancer effect by vaccination with a single kind of WT1 peptide.
    Oka Y; Tsuboi A; Fujiki F; Li Z; Nakajima H; Hosen N; Shirakata T; Nishida S; Oji Y; Kawase I; Sugiyama H
    Anticancer Agents Med Chem; 2009 Sep; 9(7):787-97. PubMed ID: 19538172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Cancer antigen WT1 protein-derived peptide"-based treatment of cancer -toward the further development.
    Oka Y; Tsuboi A; Fujiki F; Shirakata T; Nishida S; Hosen N; Nakajima H; Li Z; Kawase I; Oji Y; Sugiyama H
    Curr Med Chem; 2008; 15(29):3052-61. PubMed ID: 19075652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilot study of WT1 peptide-pulsed dendritic cell vaccination with docetaxel in esophageal cancer.
    Matsuda T; Takeuchi H; Sakurai T; Mayanagi S; Booka E; Fujita T; Higuchi H; Taguchi J; Hamamoto Y; Takaishi H; Kawakubo H; Okamoto M; Sunamura M; Kawakami Y; Kitagawa Y
    Oncol Lett; 2018 Jul; 16(1):1348-1356. PubMed ID: 29963201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma.
    Sakai K; Shimodaira S; Maejima S; Udagawa N; Sano K; Higuchi Y; Koya T; Ochiai T; Koide M; Uehara S; Nakamura M; Sugiyama H; Yonemitsu Y; Okamoto M; Hongo K
    J Neurosurg; 2015 Oct; 123(4):989-97. PubMed ID: 26252465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma.
    Fukuda K; Funakoshi T; Sakurai T; Nakamura Y; Mori M; Tanese K; Tanikawa A; Taguchi J; Fujita T; Okamoto M; Amagai M; Kawakami Y
    Melanoma Res; 2017 Aug; 27(4):326-334. PubMed ID: 28263240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzyme-Linked Immunosorbent Spot Assay for the Detection of Wilms' Tumor 1-Specific T Cells Induced by Dendritic Cell Vaccination.
    Higuchi Y; Koya T; Yuzawa M; Yamaoka N; Mizuno Y; Yoshizawa K; Hirabayashi K; Kobayashi T; Sano K; Shimodaira S
    Biomedicines; 2015 Dec; 3(4):304-315. PubMed ID: 28536414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic Cell-Based Adjuvant Vaccination Targeting Wilms' Tumor 1 in Patients with Advanced Colorectal Cancer.
    Shimodaira S; Sano K; Hirabayashi K; Koya T; Higuchi Y; Mizuno Y; Yamaoka N; Yuzawa M; Kobayashi T; Ito K; Koizumi T
    Vaccines (Basel); 2015 Dec; 3(4):1004-18. PubMed ID: 26690485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer Immunology and Immunotherapy.
    Sukari A; Nagasaka M; Al-Hadidi A; Lum LG
    Anticancer Res; 2016 Nov; 36(11):5593-5606. PubMed ID: 27793882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma.
    Lee JH; Lee Y; Lee M; Heo MK; Song JS; Kim KH; Lee H; Yi NJ; Lee KW; Suh KS; Bae YS; Kim YJ
    Br J Cancer; 2015 Dec; 113(12):1666-76. PubMed ID: 26657650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient induction of anti-tumor immune response in esophageal squamous cell carcinoma via dendritic cells expressing MAGE-A3 and CALR antigens.
    Liu X; Song N; Liu Y; Liu Y; Li J; Ding J; Tong Z
    Cell Immunol; 2015 Jun; 295(2):77-82. PubMed ID: 25863743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune responses in patients with esophageal cancer treated with SART1 peptide-pulsed dendritic cell vaccine.
    Narita M; Kanda T; Abe T; Uchiyama T; Iwafuchi M; Zheng Z; Liu A; Kaifu T; Kosugi S; Minagawa M; Itoh K; Takahashi M
    Int J Oncol; 2015 Apr; 46(4):1699-709. PubMed ID: 25625346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society.
    Kuwano H; Nishimura Y; Oyama T; Kato H; Kitagawa Y; Kusano M; Shimada H; Takiuchi H; Toh Y; Doki Y; Naomoto Y; Matsubara H; Miyazaki T; Muto M; Yanagisawa A
    Esophagus; 2015; 12(1):1-30. PubMed ID: 25620903
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer.
    Mayanagi S; Kitago M; Sakurai T; Matsuda T; Fujita T; Higuchi H; Taguchi J; Takeuchi H; Itano O; Aiura K; Hamamoto Y; Takaishi H; Okamoto M; Sunamura M; Kawakami Y; Kitagawa Y
    Cancer Sci; 2015 Apr; 106(4):397-406. PubMed ID: 25614082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoantigen in esophageal squamous cell carcinoma for dendritic cell-based cancer vaccine development.
    Forghanifard MM; Gholamin M; Moaven O; Farshchian M; Ghahraman M; Aledavood A; Abbaszadegan MR
    Med Oncol; 2014 Oct; 31(10):191. PubMed ID: 25178937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer.
    Koido S; Homma S; Okamoto M; Takakura K; Mori M; Yoshizaki S; Tsukinaga S; Odahara S; Koyama S; Imazu H; Uchiyama K; Kajihara M; Arakawa H; Misawa T; Toyama Y; Yanagisawa S; Ikegami M; Kan S; Hayashi K; Komita H; Kamata Y; Ito M; Ishidao T; Yusa S; Shimodaira S; Gong J; Sugiyama H; Ohkusa T; Tajiri H
    Clin Cancer Res; 2014 Aug; 20(16):4228-39. PubMed ID: 25056373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction therapy for esophageal cancer.
    Paul S; Altorki N
    Thorac Surg Clin; 2013 Nov; 23(4):499-507. PubMed ID: 24199700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oesophageal carcinoma.
    Pennathur A; Gibson MK; Jobe BA; Luketich JD
    Lancet; 2013 Feb; 381(9864):400-12. PubMed ID: 23374478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial.
    Miyatake T; Ueda Y; Morimoto A; Enomoto T; Nishida S; Shirakata T; Oka Y; Tsuboi A; Oji Y; Hosen N; Nakatsuka S; Morita S; Sakamoto J; Sugiyama H; Kimura T
    J Cancer Res Clin Oncol; 2013 Mar; 139(3):457-63. PubMed ID: 23160854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trial of the intratumoral administration of labeled DC combined with systemic chemotherapy for esophageal cancer.
    Fujiwara S; Wada H; Miyata H; Kawada J; Kawabata R; Nishikawa H; Gnjatic S; Sedrak C; Sato E; Nakamura Y; Sakakibara M; Kanto T; Shimosegawa E; Hatazawa J; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Nakayama E; Mori M; Doki Y
    J Immunother; 2012 Jul; 35(6):513-21. PubMed ID: 22735809
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.